You are here

  • Home
  • Archive
  • Volume 4, Issue 3
  • Comprehensive follow up care reduced life threatening illnesses without increasing costs in high risk, inner city infants

Article Text

Article menu
Download PDFPDF
Treatment
Comprehensive follow up care reduced life threatening illnesses without increasing costs in high risk, inner city infants

https://doi.org/10.1136/ebn.4.3.78

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Broyles RS, Tyson JE, Heyne ET, et al.Comprehensive follow-up care and life-threatening illnesses among high-risk infants. A randomized controlled trial.JAMA2000 Oct 25;284:2070–6OpenUrlCrossRefPubMedWeb of Science

    QUESTIONS: Does access to comprehensive follow up care reduce life threatening illnesses among high risk, inner city infants? Is it cost effective?

    Design

    Randomised (allocation concealed), blinded (outcome assessors) controlled trial with follow up to age 1 year.

    Setting

    A follow up clinic in a private children's hospital in Dallas county, Texas, USA.

    Patients

    887 infants who either weighed <1000 g at birth or weighed between 1001 and 1500 g and received mechanical ventilation in the first 48 hours after birth. 783 infants (88%) were included in the primary analysis (mean maternal age 23 y; 54% black, 31% Hispanic). At 1 year follow up, 37 infants had unknown outcomes.

    Intervention

    446 infants were allocated to comprehensive follow up care and 441 were allocated to routine care. Both groups were cared for …

    View Full Text

    Footnotes

    • Sources of funding: Agency for Healthcare Research and Quality; North Texas Chapter of the National Foundation March of Dimes.

    • For correspondence: Dr J E Tyson, University of Texas-Houston Medical School, 6431 Fannin Street, MSB 3.228, Houston, TX 77030–1503, USA. Fax +1 713 500 0519.